“Who’s Young-ran Kim?” Act known by big pharmas’ headquarters

Not long ago, an officer from a multinational pharmaceutical company’s headquarters asked a question to a reporter.

“Who’s Young-ran Kim?”

The ‘Anti-Corruption and Bribery Prohibition Act’ which will be enforced on the coming September, also known as the ‘Kim Young-ran Act,’ seems widely known even in the international pharmaceutical industry, too.

Considering the size of the market, the pha...